Teytz, Y., Ronen, D., Vansover, A., Stematsky, T. and Riggs, J.L. (1994) Inhibition of Human Immunodeficiency Virus by N-methylisatin-beta 4':4'-Diethylthiosemi- carbazoneand N-Allylisatin-beta4':4'-diallythiosemicarbazone. Antiviral Research, 24, 305-314.
https://doi.org/10.1016/0166-3542(94)90077-9

has been cited by the following article:

• TITLE: Synthesis, Molecular Structure and Antibacterial Activity of Benzylmethyl-4-Methyl-3-Thiosemicarbazone

  AUTHORS: James A. Mbah, Godfred A. Ayimele, Elvis N. Eyonganyoh, Emmanuel N. Nfor

  KEYWORDS: Benzylmethyl-4-Methyl-3-Thiosemicarbazone, Antibacterial Activity, Crystal Structure

  JOURNAL NAME: International Journal of Organic Chemistry, Vol.7 No.2, May 24, 2017

  ABSTRACT: A novel Schiff base, benzylmethyl-4-methyl-3-thiosemicarbazone (BMM) de-rived from benzylmethylketone and 4-methylthiosemicarbazide was synthe-sized and characterized by elemental analysis, spectroscopic methods (IR, 1H NMR, 13C NMR) and physical means. The single crystal structure analysis of the Schiff base reveals that it crystallizes in a monoclinic system in the P21/c space group. BMM revealed moderate antibacterial activity on three bacterial strains with diameter zone of inhibition of 16 mm (E. coli), 14 mm (K. pneumonia) and 13 mm (S. epider-midis) compared with the standard drug, ciprofloxacin.